IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: I. Luttichuys who wrote (828)	5/8/1997 9:22:00 PM
From: Don Cheng	of 1762

Hi Bennett, I am afraid that the biotech industry may have to take a bath tomorrow because of Motrophine (Cephalon) did not win the FDA advisory panel approval today. In fact, Cephalon already indicated that they were not going to invest more money on this product becuase of the hugh investment (120 million ?) in the past. I do not think short-term but long-term now. Don

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next